middle.news
How Pathkey.AI’s New Partnership Could Revolutionise Early-Phase Clinical Trials
8:57am on Wednesday 12th of November, 2025 AEDT
•
Healthcare
Read Story
How Pathkey.AI’s New Partnership Could Revolutionise Early-Phase Clinical Trials
8:57am on Wednesday 12th of November, 2025 AEDT
Key Points
Five-year Master Collaboration Agreement signed between Pathkey.AI and Armstrong Clinical
Integration of AI-powered TrialKey platform with clinical development expertise
Focus on optimising early-phase clinical trial design and reducing development risks
Joint projects to enhance Australia’s role in global early-stage clinical research
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pathkey.AI (ASX:PKY)
OPEN ARTICLE